Jeremy McCormick, MD
Foot and Ankle Surgery · Saint Louis, MONPI 1265585111
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $976,698 of the $1,462,537 with a category attached, or 66.8%. Stryker accounts for 98.5% of it on its own, with 13 other manufacturers making up the rest. Among foot and ankle surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,149 payments — averaging $1272.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1.4M
- Arthrex$15K
- Elite Orthopedics, LLC$4K
- Seaspine Orthopedics Corporation$850
- Acera Surgical, Inc.$487
- Trice Medical, Inc.$435
- plus $1K from 8 others
Across 20 payments — averaging $101.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$2K
What the payments were for
- Royalty or licence$279,01019%
- Consulting fees$976,69867%
- Speaking & faculty fees$50,7823%
- Travel & lodging$127,7629%
- Food & beverage$22,0682%
- Education$6,2180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 1,078 | $1,440,716 |
| Arthrex | 34 | $15,198 |
| Elite Orthopedics, LLC | 8 | $3,647 |
| Seaspine Orthopedics Corporation | 7 | $850 |
| Acera Surgical, Inc. | 6 | $487 |
| Trice Medical, Inc. | 4 | $435 |
| Paragon 28, Inc. | 2 | $275 |
| Johnson & Johnson | 3 | $264 |
| 4web, Inc. | 1 | $147 |
| DJO, LLC | 1 | $138 |
| Medline Industries LP | 2 | $130 |
| Linvatec Corporation | 1 | $128 |
| Smith+Nephew | 1 | $105 |
| Biocomposites Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$392,203
- ORTHOLOC 2 LAPIFUSE$319,150
- PROPHECY$246,087
- INBONE$245,928
- PROstep$132,773
- HOFFMANN$86,173
- INVISION$82,703
- FIXOS$37,124
- OMEGA$36,340
- ES2 SPINAL SYSTEM$34,238
- R&D Foot and Ankle$31,789
- MAKO$31,325
- INCOMPASS TOTAL ANKLE SYSTEM$28,175
- VARIAX$24,409
- SALVATION$23,789
- GRAVITY$19,725
- AXSOS$18,865
- STAR$17,529
- GAMMA$16,665
- ALLOWRAP$15,400
How this compares
$1,462,537 in reported general payments places this provider in the 95th percentile of 163 foot and ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 36 | $116 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Saint Louis
- Jeffrey JohnsonSaint Louis$944K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
- Seth AndersonSaint Louis$45K
- Kelly HynesSaint Louis$34K
- Lindsay BarthSaint Louis$30K
- Andrew ThomeSaint Louis$24K
- Timothy OldaniSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.